ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

BASIC FACTS
DATE OF LAUNCH

18 MAY 1992

CATEGORY

EQUITY

TYPE

FLEXI CAP

AUM*

Rs.26,503 crore

BENCHMARK

NIFTY 500 TOTAL

RETURN INDEX

WHAT IT COSTS

NAV**

GROWTH OPTION

Rs.237.24

IDCW

Rs.156.85

MINIMUM INVESTMENT

Rs.5,000

MINIMUM SIP AMOUNT

Rs.500

EXPENSE RATIO*** (%)

1.82

EXIT LOAD

For units in excess of 10% of the investment,1% will be charged for redemption within 365 days

*AS ON 31 AUGUST 2022
**AS ON 27 SEPTEMBER 2022
***AS ON 31 AUGUST 2022

FUND MANAGER
AJAY TYAGI

TENURE: 6 YEARS, 7 MONTHS

Recent portfolio changes
Complete Exits: Cera Sanitaryware, La Opala RG.

Increasing allocation: 3M India, Aavas Financiers, Asian Paints, Astral, Avenue Supermarts, Berger Paints India, Coforge, ICICI Bank, Info Edge (India), MindTree, Poly Medicure, Rossari Biotech, Titan Company, Zomato.

Should you buy?

Run as a large-cap oriented fund in its earlier avatar as UTI Equity, this fund retains its large cap tilt under revised flexi cap mandate. The fund manager adopts a distinct quality and growth bias for its portfolio. It is well diversified, yet retains healthy positions in its top bets. The fund regained its consistency in outperformance soon after the current fund manager took over its reins. However, it has experienced a dip over the past year as the market preferences shifted away from growth. It continues to retain a strong long term track record and should find a way back in the hands of its proven fund manager.

(Source: Value Research)